Drug Database
Back to search

Poland· PL-100096072

Robitussin Expectorans

A guaifenesin product containing guaifenesinum, registered in Poland by Haleon Poland Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC R05CA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRobitussin ExpectoransATCR05CA03REGISTER NO.PL-100096072PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about guaifenesinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Guaifenesin is registered in 14 of 19 countries.

Countries holding a registration under ATC R05CA03 (guaifenesin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search guaifenesin products by name

Guaifenesin · ATC R05CA03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of guaifenesin costs, country by country.

Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Guaifenesin · price per daily dose (0.9 g)

USD · FX 28 Sept 2026

  • US United States$0.29 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Guaifenesinum
Manufacturer
Haleon Poland Sp. z o.o.
Country
Poland (PL)
ATC code
R05CA03
ATC class
Guaifenesin
Defined daily dose
0.9 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990821617

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Guaifenesin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All guaifenesin products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Bronchostop Akut, Grippostad Guaifenesin
  • Belgium · Bronchosedal Mucus Honig & Zitrone, Bronchosedal Mucus Honing & Citroen
  • Cyprus · Benylin Mucus Cough Warm Honey & Lemon Flavour
  • Czechia · Guajacuran, Medexpecto Vicks Sirup Med A Zázvor
  • Germany · Fagusan, Wick Husten-Löser Mit Honigaroma
  • Denmark · Benysine
  • Estonia · Expexin
  • Spain · Formulaexpec, Frispec
  • France · Vicks Expectorant Adultes Miel
  • United Kingdom (Northern Ireland) · Bell’s Healthcare Mucus Cough, Benylin Children's Chesty Coughs
  • Greece · Hexacough Warm Honey & Lemon
  • Hungary · Relaxil-G, Robitussin Expectorans
  • Ireland · Benylin Children's Chesty Cough, Benylin Mucus Cough Honey & Lemon
  • Iceland · Túfen
  • Italy · Actigrip Tosse Mucolitico "gusto Mentolo”, Vicks Tosse Fluidificante
  • Lithuania · Expexin
  • Luxembourg · Bronchosedal Mucus Menthol, Bronchosedal Mucus Miel & Citron
  • Latvia · Expexin
  • Norway · Benysine Med Honning- Og Sitronsmak, Solvipect
  • Portugal · Vicks Expectorante Mel
  • Romania · Robitussin Expectorans, Vicks Expectorant
  • Sweden · Nipenesin, Nipenesin Mentol
  • Slovakia · Guajacuran, Robitussin Expectorans Na Vykašliavanie

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c682dee8-7615-4654-b8f8-b7228b5ade16
GET /v1/drugs/c682dee8-7615-4654-b8f8-b7228b5ade16?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Syrop",
  "source": "urpl",
  "strength": "100 mg/5 ml",
  "packaging": "05909990821617 ¦ OTC ¦ 16024\n1 butelka 100 ml",
  "substance": "Guaifenesinum 100 mg/5 ml",
  "common_name": "Guaifenesinum",
  "pl_product_id": "100096072",
  "pozwolenie_nr": "08216",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about guaifenesin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console